Shared on 27 Oct 25
Fair value Increased 6.82%Analysts have increased their price target for SMA Solar Technology from €17.60 to €18.80. This change reflects improved revenue growth expectations and stronger near-term demand.
Shared on 03 Sep 25
Fair value Decreased 5.38%EMEA Price Pressure And US Backlog Will Shape Energy Transition
Due to downward revisions in both consensus revenue growth and net profit margin forecasts, analysts have reduced SMA Solar Technology’s fair value estimate, lowering the consensus price target from €18.60 to €17.60. What's in the News Preliminary H1 2025 results indicate sales of €684.9 million, down from €759.3 million in H1 2024, and a loss before interest and taxes of €19.0 million compared to a profit of €56.2 million.
Shared on 08 Aug 25
Fair value Increased 4.49%EMEA Price Pressure And US Backlog Will Shape Energy Transition
The upward revision in SMA Solar Technology’s fair value is primarily supported by a modest increase in the company’s Future P/E multiple, with the consensus analyst price target rising from €17.80 to €18.80. What's in the News Preliminary H1 2025 results show sales of €684.9 million, down from €759.3 million H1 2024, and LBIT of €19.0 million versus EBIT of €56.2 million prior year.
Shared on 30 Jul 25
Fair value Increased 7.29%EMEA Price Pressure And US Backlog Will Shape Energy Transition
The analyst price target for SMA Solar Technology has been revised upward to €17.80, primarily reflecting improved revenue growth forecasts, despite a higher discount rate. What's in the News Preliminary H1 2025 results indicate sales of €684.9 million, down from €759.3 million in H1 2024, with a loss before interest and taxes (LBIT) of €19.0 million versus a gain of €56.2 million in H1 2024.
Shared on 26 Mar 25
Unfavorable Market Conditions Will Impact Home And C&I Segments
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 8.85%Unfavorable Market Conditions Will Impact Home And C&I Segments
AnalystConsensusTarget made no meaningful changes to valuation assumptions.